BriefNews — World News, Updated Every Minute

TechMay 14, 2026

Cerebras IPO Hits $100B Cap, Fuels AI Chip Race

Cerebras Systems Inc. executed a highly successful IPO on Nasdaq on May 14, 2026, raising $5.55 billion and achieving a market capitalization near $100 billion. The debut saw shares surge by 68%, boosting the wealth of co-founders Andrew Feldman and Sean Lie, who became billionaires. The company's success is attributed to high market demand for advanced AI chips, exemplified by its specialized Wafer Scale Engine 3. Furthermore, Cerebras secured a significant $20 billion multi-year deal with OpenAI, underscoring its critical role in the rapidly expanding AI infrastructure sector.

Ad slot

TechMay 14, 2026

Cerebras AI Chip Stock: Jim Cramer's Caution on Valuation

Jim Cramer advised caution regarding Cerebras Systems' stock following its recent IPO, warning that the current valuation is excessively high. While acknowledging the company's advanced AI chip technology and major partnerships with OpenAI and AWS, Cramer stressed that the stock's rapid ascent has stretched its valuation significantly. He noted that the stock traded at a high multiple relative to its sales compared to industry peers. Cramer recommended that investors wait for a substantial market pullback before considering an investment, emphasizing the risk associated with current pricing.

BusinessMay 14, 2026

Gemini Stock Surges After $100M Winklevoss Fund Investment

Gemini, the crypto exchange, experienced a stock surge after securing a $100 million capital injection from the Winklevoss Capital Fund. The investment underscores the company's strategic pivot from a pure crypto exchange to a broader market platform. Financially, Gemini reported a narrower-than-expected quarterly loss and total revenue exceeding forecasts. While exchange revenue declined by 27%, credit card and services revenue showed significant year-over-year growth. Executives emphasized that this funding will fuel the transition, aiming to stabilize revenue streams beyond crypto market fluctuations.

HealthMay 14, 2026

Supreme Court Allows Mifepristone Mail Order Pending Appeal

The U.S. Supreme Court has permitted the mail-order dispensing of the abortion drug mifepristone while an appeal challenging this distribution method is ongoing. The ruling, announced on Thursday, followed a demonstration at the Supreme Court in Washington, D.C., on March 26, 2024. The Court declined to specify the vote count supporting the continuation of the stay or provide a majority explanation. Notably, conservative justices Clarence Thomas and Samuel Alito issued written dissents regarding the decision.

PoliticsMay 14, 2026

Trump-Linked Cuts: US Troop Reductions in Europe Revealed

Defense Secretary Pete Hegseth reportedly canceled major US military deployments to Europe, including rotations through Poland and the withdrawal of a long-range missile battalion from Germany. These actions are attributed to dissatisfaction with the level of defense contributions from European allies, particularly Germany. While the Pentagon aims to signal that allies must assume primary defense responsibility, the move has drawn criticism from some members of Congress. Despite the troop adjustments, military leaders maintain that Russia continues to pose a substantial and enduring threat to US interests in the region.

HealthMay 14, 2026

Supreme Court Allows Telehealth Access to Mifepristone, Pauses Ruling

The U.S. Supreme Court has temporarily allowed women to continue accessing the abortion pill mifepristone through telehealth appointments, preserving the existing access status. This decision paused a prior ruling from the Fifth U.S. Circuit Court of Appeals that had required in-person dispensing. The substantive legal questions will now be addressed by the New Orleans-based appeals court. Justices Clarence Thomas and Samuel Alito dissented from the ruling, citing concerns over the legal basis and the implications for previous Supreme Court decisions. The Court did not issue a written rationale or disclose the vote count.

PoliticsMay 14, 2026

Dems Demand Lutnick Resign Over Epstein Interview Lies

House Democrats have demanded the resignation of Commerce Secretary Howard Lutnick following revelations from newly released files concerning Jeffrey Epstein. The core accusation is that Lutnick publicly lied about the nature and extent of his relationship with Epstein. Democrats pointed to a contradiction between Lutnick's earlier claims of never associating with Epstein after 2005, and his later admission of meeting him on a private island in 2012. The Department of Commerce dismissed the allegations, calling the demands politically motivated distractions. Meanwhile, the White House affirmed its continued support for Lutnick.

TechMay 14, 2026

Cisco's Surge Boosts Broadcom: 3 Key AI Drivers

Cisco's earnings report, which showed a 15% stock surge, highlighted robust demand for networking solutions driven by AI data center buildouts, reporting $5.3 billion in AI infrastructure orders year-to-date. This positive momentum extended to Broadcom, whose stock rose over 5%. Key drivers for both companies include the massive spending by hyperscalers on AI infrastructure, the increasing need for low-latency networking for advanced AI applications like inference, and enterprise-wide mandates to modernize networks to handle anticipated traffic tripling. Analysts suggest this points to a sustained 'networking super cycle' benefiting both firms.

BusinessMay 14, 2026

SpaceX IPO Prospectus Expected Next Week; $70B+ Target

Sources suggest SpaceX is preparing to release its IPO prospectus next week, following a confidential filing in April. The company plans to launch its investor roadshow on June 8th, aiming for a massive listing size estimated between $70 billion and $75 billion. This potential offering follows SpaceX's merger with xAI, which valued the combined entity at $1.25 trillion. Due to the scale, advisors are targeting unique sales channels, including international retail investors. The market interest is heightened by the current focus on high-valuation IPOs within the Artificial Intelligence sector.

TechMay 14, 2026

Cerebras IPO: AI Chip Debut vs. Tech Giants' Valuations

Cerebras Systems debuted its AI chip technology during an IPO on May 14, 2026, with shares rising 68% to achieve a market cap of about $95 billion. This valuation was lower than the historical first-day market caps of tech giants like Alibaba ($231B) and Facebook ($104B). Financially, Cerebras reported $510 million in 2025 revenue. Crucially, the company bolstered its profile by announcing a multi-year deal with OpenAI worth over $20 billion and establishing a partnership with Amazon Web Services.

MarketsMay 14, 2026

Stagflation Risk Hits 40% by 2026, Say Traders

Traders on the Kalshi platform estimate that the risk of U.S. stagflation—high inflation paired with unemployment—has climbed to nearly 40% by the end of 2026. This concern follows the BLS reporting a 3.8% year-on-year CPI for April, the highest since May 2023. Furthermore, traders predict a high probability of inflation remaining above 4.5% this year. While the unemployment rate remained at 4.3% in April, analysts are drawing comparisons to the oil shocks of the 1970s amid these economic indicators.

MarketsMay 14, 2026

BofA: ETFs to Bolster Portfolios Against Inflation Risks

Amid persistent inflation, Bank of America advises investors to re-evaluate traditional asset allocations, moving beyond a sole focus on technology and US Treasuries. The bank's strategists recommend hedging against potential stagflation by investing in real assets, value stocks, and specific commodity sectors. Key recommendations include ETFs tracking metals and mining (like IYM), MLPs (such as TPYP), and nuclear power (URA). Furthermore, the report suggests exploring international and domestic small-cap value ETFs (AVDV and SVAL) as cost-effective diversification tools.

PoliticsMay 14, 2026

Trump's Iran War Comments: Financial Gaffe Undermines Leverage

Donald Trump's assertion that American financial concerns are irrelevant when discussing the Iran conflict has drawn political scrutiny. While some Republicans attempted to downplay the comments, Vice President JD Vance offered a more measured acknowledgment of economic difficulties like inflation. Analysts suggest that while dismissing finances might signal strength to Iran, it risks undermining Trump's domestic political standing. The article notes that the war is already unpopular, and the economy remains the dominant issue for voters, potentially increasing pressure on Trump to seek an end to the conflict.

HealthMay 14, 2026

ALS Care Costs: How 4 Americans Face 'Bankruptcy Disease'

ALS is a progressive, terminal neurodegenerative disease with escalating care costs. Studies indicate that the average first-year cost for Medicare-enrolled patients is substantial, with major expenses stemming from hospital stays and durable medical equipment. Successful navigation of this crisis often relies on proactive financial planning, insurance coverage, and support from sources like the Veterans Affairs (VA). Patients interviewed highlighted the necessity of these strategies, while also emphasizing the importance of open conversations regarding end-of-life care arrangements.

PoliticsMay 14, 2026

Lawmakers Warn: Chinese Parts Already in U.S. Cars

Lawmakers are cautioning the White House against using the U.S. auto market as a bargaining chip with China, citing deep existing supply chain dependencies. Concerns center on the potential threat to domestic manufacturing jobs if subsidized Chinese automakers gain a foothold in the U.S. market. Despite major Chinese brands lacking direct retail presence, over 60 U.S. auto suppliers are owned by Chinese entities. Furthermore, components sourced from China have been identified in vehicles from major manufacturers like Toyota, Ford, and GM. This complex entanglement complicates any potential trade policy aimed at limiting Chinese market access.

WorldMay 14, 2026

Homo erectus Teeth Reveal Molecular Links to Modern Humans

Scientists analyzed ancient enamel proteins from six *Homo erectus* teeth, dating back 400,000 years, establishing a molecular link to later human species. The research revealed an unknown amino acid variant shared with Denisovans and modern humans, suggesting past interbreeding events. This evidence supports a model of human evolution as a complex network of interacting populations rather than isolated lineages. The study also successfully determined the sex of the specimens. Experts suggest these findings bolster theories of admixture between various hominin groups, though further DNA analysis is needed for a complete picture.

MarketsMay 14, 2026

Retail Investors Drive Market Rally: Goldman Sachs Picks Stocks

Goldman Sachs reports that individual retail investors are currently leading the market rally, driving the S&P 500 to record highs. Trading volumes from these investors have surged 28% since mid-April, fueled by strong interest in Artificial Intelligence. Key favored stocks include Nvidia, Micron Technology, and Advanced Micro Devices, which are showing significant gains. However, the analysis also notes that retail traders are heavily investing in declining stocks, such as American Airlines Group and Nu Holdings, indicating a high-risk appetite that increases market volatility.

PoliticsMay 14, 2026

FBI Offers $200K for Former Air Force Spy Linked to Iran

The FBI has posted a $200,000 reward for information leading to the capture of Monica Witt, a former Air Force intelligence specialist. Witt is accused of defecting to Iran in 2013 and subsequently spying for Iranian interests. Prosecutors allege that between 2012 and 2015, she provided sensitive U.S. national defense information to Iran. The FBI is actively seeking information to bring her to justice, emphasizing the seriousness of the alleged espionage activities. The indictment also charged four Iranian individuals with related crimes.

TechMay 14, 2026

Cerebras IPO Soars: Chipmaker Hits $100B Market Cap

Cerebras Systems debuted on the Nasdaq with a strong performance, opening at $350 per share and valuing the chipmaker at over $100 billion. The IPO raised $5.55 billion from the sale of 30 million shares, marking the largest U.S. tech IPO since Uber in 2019. The company's success is attributed to the booming artificial intelligence sector, which is driving demand for advanced semiconductors. Market analysts suggest this signals a potential wave of future AI-focused IPOs, with companies like SpaceX and OpenAI mentioned as potential next listings.

BusinessMay 14, 2026

Generac Stock: AI Infrastructure Story Signals Long-Term Buy

Generac is being analyzed as a crucial supplier for the growing Artificial Intelligence (AI) infrastructure, moving beyond its traditional role. Fundamentally, the company benefits from increased demand for reliable backup power by hyperscale data centers, evidenced by stronger commercial and industrial sales and an elevated 2026 sales outlook. Technically, the stock shows signs of being overbought in the short term, suggesting potential pullbacks. However, the long-term outlook is highly positive, highlighted by the formation of a 'golden cross' on the weekly chart, signaling a strong, sustained uptrend for patient, long-term investors.

MarketsMay 14, 2026

Goldman Sachs: Tech Stock 'Up Crash' Signals Further Gains

Goldman Sachs has analyzed current market conditions, suggesting that the rapid rally in tech stocks is generating a unique volatility dynamic. This pattern of rapid gains followed by sustained increases has historically occurred only four times. Despite the S&P 500 rising 7% since mid-April, the VIX index has remained stable below 18. This stability is attributed to aggressive call buying in growth stocks and general market hedging. Furthermore, the correlation between the Nasdaq 100 and its one-month call option price is positive for the fourth time in the past decade, signaling potential further gains.

PoliticsMay 14, 2026

CNN Poll: Trump's Economic Performance Faces Major Criticism

A recent CNN poll reveals that 70% of Americans disapprove of President Donald Trump's management of the economy, a figure significantly higher than previous measurements. The poll identifies tariffs and the conflict with Iran as major catalysts for this increased disapproval. Key findings show that 65% of Americans believe his policies have worsened economic conditions, and 77% feel the cost of living has risen due to his actions. The data suggests that these specific policies are being directly blamed for negative impacts on personal finances, even among some Republicans.

MarketsMay 14, 2026

Jim Cramer Targets TJX Stock After 10% Dip, Highlights Cyber Stocks

During a recent 'Morning Meeting,' Jim Cramer observed that major US indexes rallied, with the Dow Jones reclaiming 50,000. He noted sector divergence in semiconductors, suggesting Cerebras's focus might be drawing capital from other AI chip stocks. Cramer highlighted cybersecurity stocks, such as Palo Alto Networks and CrowdStrike, which remained strong, despite AI concerns. Furthermore, he pointed to TJX Companies as a potential buying opportunity, given its recent 10% pullback amid consumer spending worries. The analysis emphasized these sectors as key areas for investors to monitor.

HealthMay 14, 2026

Biogen Advances Alzheimer's Drug to Late-Stage Trial Despite Data Hurdles

Biogen plans to advance its experimental drug targeting tau protein for Alzheimer's disease into Phase 3 clinical trials, despite disappointing efficacy data observed at higher doses in mid-stage testing. The company cited compelling evidence suggesting that the drug successfully reduces tau levels and slows cognitive decline, particularly at lower dosages. This marks a continued effort by Biogen in the challenging field of Alzheimer's research, following previous developments with drugs like Aduhelm and Leqembi. The drug's mechanism differs from previous Biogen treatments, which focused on amyloid removal. The decision to proceed places Biogen in direct competition with rivals like Eli Lilly in the pursuit of tau-targeting therapies.